Home > Eu Project Profile > INNOLABS
General Information
Programme: 
H2020-INNOSUP-1-2015
Project duration: 
Sunday, 1 January, 2017 to Sunday, 30 June, 2019
Project website: 
Total budget: 
€5.000.000
EU Contribution: 
€5.000.000
Partnership Composition: 
Organisation nameFunctionCountryWebsite linkECCP linkIs Cluster Organisation ?
Oslo MedTech
Coordinator
Norway
Yes
Berlin Partner
Partner
Germany
No
Campania BioScience
Partner
Italy
No
Cap Digital
Partner
France
Yes
Cluster de Salud de Castilla y Leon
Partner
Spain
Yes
Eurob Creative
Partner
Spain
No
Health ClusterNET
Partner
United Kingdom
Yes
Interizon Pomarian ICT Cluster
Partner
Poland
Yes

INNOLABS project aims to unlock the cross-sectoral collaborative potential of SMEs by combining ICT with the BIO, Health, and Medicine sectors to deliver market sensitive disruptive technologies and potentially using mHealth as a catalyst, and applying such results to personalized health for elderly populations. 

The innovations created by the combination of different value chains need to get to market fast and adapt to constantly changing end-user needs. INNOLABS will study the characteristics in market dynamics and specificities for innovations created by merging ICT and biomedical research.

Objectives:

INNOLABS project aims to unlock the cross-sectoral collaborative potential of SMEs by combining ICT with the BIO, Health, and Medicine secotrs to deliver market sensitive disruptive technologies and potentially using mHealth as a catalyst, and applying such results to personalized health for elderly populations. The project intends to achieve the following specific objectives:

  • Test and validate optimal support measures for taking merged ICT and biomedical research products and services to market.
  • Increase the competitiveness of SMEs by using targeted non-monetary support mechanisms that generate added value encompassing expert knowledge, new partnerships and market optimisation of products.
  • Secure new funding streams to facilitate sustainable cycles of collaborative innovation by SMEs.

Sectoral/industrial focus: ICT, BIO, Health, Medicine

Executive Summary:

INNOLABS project aims at supporting cross-sectoral collaboration among SMEs from ICT, BIO, Health and Medicine (IBHM) sectors, with a practical application of results mainly to m-health and personalized e-health for elderly populations in both rural and urban areas.

The innovations created by the combination of different value chains need to get to market fast and adapt to constantly changing end-user needs. INNOLABS will study the characteristics in market dynamics and specificities for innovations created by merging ICT and biomedical research.

INNOLABS is based on three main concepts:

  • Long term sustainability. INNOLABS will facilitate access to (i) private Venture Capital equity; (ii) new funding sources, like for example crowdfunding; (iii) promote additional public funding opportunities and instruments to the participating teams, highlighting their characteristics, advantages and inconvenients.
  • Support services. INNOLABS will provide non-monetary support measures, such as expert platforms with beta-testers or matchmaking tools.
  • Funding. INNOLABS will directly provide to SMEs financial support in the form of direct funding, innovation services and innovation vouchers for external consultants.

Selected SMEs will have the possibility to opt to a fast lane acceleration process: 3 months of execution for the same amount of funding and intense support. This innovative approach specifically respond to the needs of fast markets like the mHealth market.

Expected Results:

  • Provide a catalogue of monetary and non-monetary measures provided by regional innovation clusters to support SMEs innovation.
  • Increase the competitiveness of the SMEs by supporting the delivery of timely and innovative products and services.
  • Advance the positioning of European countries in new emerging markets.
  • Achieve long-term sustainability of more than 100 innovative project ideas.

Events organized by the project:

  • Two large contest idea events. Innovative ideas will be generated and developed through online and onsite meetings and workshops. SMEs will join up with SMEs from other sectors and/or countries to collaborate in developing these ideas further. Those collaborations with the best ideas will be selected to develop a prototype and receive 30k€ in direct support funding and additional 20k for innovation services and vouchers.
  • Three hackathons. These events will serve to publicly display new innovative technologies, and to provide the opportunity for SMEs active in the ICT, Bio, Health, and Medicine industries to get to know each other and work together in joint idea creation and development. Several small prizes (of 15k€ each, 4 prizes per event) will be awarded to those most promising ideas and projects.
  • University student competition. Three boot camps will support students and young innovators in the generation of original ideas for health innovations. These ideas will then be pitched to local SMEs from ICT, Bio, Health and Medicine, which will support the technical development of the idea in partnership with the students and the student’s host university/college. The two best ideas generated by student/SME collaborations will be awarded with 25k€ for the ‘hosting’ SME for further investment in the idea to help bring it closer to market.
  • Final workshop in Oslo. INNOLABS final workshop will showcase its results, the most significant ideas/projects, and present the INNOLABS White Book. A final prize of 50k€ will be awarded to the best performing SME selected from among all those previously awarded.

 

The First INNOLABS Open Call opened on 15 June 2017 and will close on 30 September 2017. This call for innovative projects in personalized healthcare is seeking applications targeting a combination of ICT, BIO, Health and Medical sectors for the benefit of ageing populations and rural areas that incorporate mHealth technologies and bring society closer to the next generation healthcare system. 

Detailed information on the call including eligibility, selection and award criteria is available on the project website and on the Participant Portal.